WASHINGTONâ€”Moves in Congress to link billions of dollars in new medical research funding to revised standards for drug and medical-device approvals are troubling some public-health experts, who say the combination makes it too easy for lawmakers to support lower patient-safety standards.

These safety advocates say legislation to beef up research funding for the National Institutes of Health should be separated from product-approval...